1. Novel Class of Anti-Diabetic Drug to Assist Type 2 Diabetics

    Research shows us that patients with type 2 diabetes mellitus (T2DM) have an impaired incretin secretion response to glucose. This finding has encouraged the development of a new class of anti-diabetic drugs classified as incretin-based therapy [1].

1 Item

To Top